An additional goal was to measure the serum levels of anti-BAFF antibodies to assess whether the complex system of anti-BAFF antibodies and BAFF-binding receptors regulating BAFF signaling could contribute to the development of SSc. The gene discussed is TNFSF13B; the disease is systemic sclerosis.